Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Premenstrual Syndrome

3,4-dihydroxyphenylacetic acid has been researched along with Premenstrual Syndrome in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sfikakis, A1
Papadopoulou-Daifotis, Z1
Sfikaki, M1
Messari, J1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Premenstrual Syndrome

ArticleYear
Monoaminergic dysregulation on diestrus-2 and estrus through high emotional reactivity.
    Pharmacology, biochemistry, and behavior, 1998, Volume: 60, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anxiety; Biogenic Monoamines; Corpus Striatum; Diestrus; Do

1998